Page last updated: 2024-09-03

gefitinib and Facial Dermatoses

gefitinib has been researched along with Facial Dermatoses in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Treudler, R; Zouboulis, CC1

Other Studies

1 other study(ies) available for gefitinib and Facial Dermatoses

ArticleYear
Follicular drug eruption induced by gefitinib (ZD 1839, iressa): clinical picture correlates with in vitro data of focal epidermal necrosis after epidermal growth factor inhibition in skin cultures.
    Dermatology (Basel, Switzerland), 2005, Volume: 211, Issue:4

    Topics: Acneiform Eruptions; Aged; Antineoplastic Agents; Cells, Cultured; Drug Eruptions; ErbB Receptors; Facial Dermatoses; Fatal Outcome; Gefitinib; Humans; Male; Protein-Tyrosine Kinases; Quinazolines; Skin; Stevens-Johnson Syndrome

2005